טוען...
Novel biomarkers for the management of chronic hepatitis B
Hepatitis B virus (HBV) cannot be eliminated completely from infected hepatocytes because of the presence of intrahepatic covalently closed circular DNA (cccDNA). As chronic hepatitis B (CHB) can progress to cirrhosis and hepatocellular carcinoma (HCC), it is important to manage CHB to prevent HCC d...
שמור ב:
| הוצא לאור ב: | Clin Mol Hepatol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Korean Association for the Study of the Liver
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364351/ https://ncbi.nlm.nih.gov/pubmed/32536045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2020.0032 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|